Read More
Language
Precise, Specific, and Sensitive De Novo Antibody Design Across Multiple Cases design
We design it from day one, revolutionizing how protein therapeutics are developed.
At Galux, we develop a pioneering protein therapeutics design platform, GaluxDesign, that uniquely integrates
artificial intelligence and physical principles.
We bring your imagined proteins to life.
Our proprietary AI platform is trained to design proteins from first principles,
resulting in
its modality-agnostic nature.
Its unprecedented accuracy has been demonstrated through the de novo design
of antibodies, one of
the most challenging protein classes to design.
![[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.](https://www.galux.co.kr/assets/images/newsroom/interview-1.png)
Join forces with Galux
to lead the next wave of drug innovation.
Together, we push boundaries
and redefine what's possible in medicine.
